Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
Pregnancy Registry Trial Novartis Recruiting N/A
500
Trial Size
0.00 0 miles
e-OPRA Implant System for Lower Limb Amputees Integrum Recruiting N/A
6
Trial Size
0.00 0 miles
Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis The Forsyth Institute Recruiting
1
Trial Phase
125
Trial Size
0.99 1 miles
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Forest Laboratories Recruiting
3
Trial Phase
1100
Trial Size
1.21 1 miles
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Novartis Recruiting N/A
3600
Trial Size
1.21 1 miles
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients PLC Medical Systems, Inc. Recruiting
3
Trial Phase
326
Trial Size
1.21 1 miles
Decision-Aid for Renal Therapy Pilot Trial Tufts University Recruiting N/A
62
Trial Size
1.21 1 miles
A Phase 2 Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) Velicept Therapeutics, Inc. Recruiting
2
Trial Phase
1200
Trial Size
1.21 1 miles
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin Menlo Therapeutics Inc. Recruiting
2
Trial Phase
200
Trial Size
1.21 1 miles
EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures Beth Israel Deaconess Medical Center Recruiting N/A
200
Trial Size
1.29 1 miles
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Dana-Farber Cancer Institute Recruiting
3
Trial Phase
660
Trial Size
1.29 1 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
1.29 1 miles
A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations Arog Pharmaceuticals LLC Recruiting
2
Trial Phase
48
Trial Size
1.29 1 miles
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
300
Trial Size
1.29 1 miles
Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy Dana-Farber Cancer Institute Recruiting
2
Trial Phase
43
Trial Size
1.29 1 miles
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection Seres Health Inc Available
2
Trial Phase
29
Trial Size
1.29 1 miles
Pain Sensitization and Habituation in a Model of Experimentally-induced Insomnia Symptoms Beth Israel Deaconess Medical Center Recruiting N/A
34
Trial Size
1.29 1 miles
Hematoma Block for Distal Radius Fracture Beth Israel Deaconess Medical Center Recruiting N/A
115
Trial Size
1.29 1 miles
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery Rutgers, The State University of New Jersey Recruiting
2
Trial Phase
82
Trial Size
1.29 1 miles
ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) Alnylam Pharmaceuticals Recruiting
3
Trial Phase
200
Trial Size
1.29 1 miles
The Young Women's Breast Cancer Study Dana-Farber Cancer Institute Recruiting N/A
1300
Trial Size
1.29 1 miles
The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study Dana-Farber Cancer Institute Recruiting N/A
290
Trial Size
1.29 1 miles
GVAX vs. Placebo for MDS/AML After Allo HSCT Dana-Farber Cancer Institute Recruiting
2
Trial Phase
152
Trial Size
1.29 1 miles
Eribulin in HER2 Negative Metastatic BrCa Dana-Farber Cancer Institute Recruiting
2
Trial Phase
90
Trial Size
1.29 1 miles
Study of Suture Repair of Torn Meniscus in the Knee Ceterix Orthopaedics, Inc. Recruiting N/A
30
Trial Size
1.29 1 miles
Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer Dana-Farber Cancer Institute Recruiting N/A
220
Trial Size
1.29 1 miles
A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease Dana-Farber Cancer Institute Recruiting
2
Trial Phase
25
Trial Size
1.29 1 miles
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults City of Hope Medical Center Recruiting N/A
700
Trial Size
1.29 1 miles
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
30
Trial Size
1.29 1 miles
Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery University of Vermont Medical Center Recruiting N/A
242
Trial Size
1.29 1 miles
Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery Baxter Healthcare Corporation Recruiting
3
Trial Phase
15
Trial Size
1.29 1 miles
Trial of a Mammography Decision Aid for Women Aged 75 and Older Beth Israel Deaconess Medical Center Recruiting N/A
550
Trial Size
1.29 1 miles
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation Beth Israel Deaconess Medical Center Recruiting N/A
100
Trial Size
1.29 1 miles
Statin Therapy in Acute Influenza Beth Israel Deaconess Medical Center Recruiting
2
Trial Phase
174
Trial Size
1.29 1 miles
Dendritic Cell Activating Scaffold in Melanoma Dana-Farber Cancer Institute Recruiting
1
Trial Phase
25
Trial Size
1.29 1 miles
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
130
Trial Size
1.29 1 miles
Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma Dana-Farber Cancer Institute Recruiting
1
Trial Phase
24
Trial Size
1.29 1 miles
Carfilzomib Plus Belinostat in Relapsed/Refractory NHL Massachusetts General Hospital Recruiting
1
Trial Phase
30
Trial Size
1.29 1 miles
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care Dana-Farber Cancer Institute Recruiting N/A
540
Trial Size
1.29 1 miles
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA Dana-Farber Cancer Institute Recruiting
2
Trial Phase
160
Trial Size
1.29 1 miles
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa Dana-Farber Cancer Institute Recruiting
2
Trial Phase
170
Trial Size
1.29 1 miles
A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors Novartis Recruiting
1
Trial Phase
92
Trial Size
1.29 1 miles
The EVICEL® Neurosurgery Phase III Study Ethicon, Inc. Recruiting
3
Trial Phase
230
Trial Size
1.29 1 miles
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) Dana-Farber Cancer Institute Recruiting
1
Trial Phase
18
Trial Size
1.29 1 miles
Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia Beth Israel Deaconess Medical Center Recruiting
3
Trial Phase
30
Trial Size
1.29 1 miles
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 Northwest Biotherapeutics Available N/A
0
Trial Size
1.29 1 miles
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique Beth Israel Deaconess Medical Center Recruiting N/A
210
Trial Size
1.29 1 miles
Trial of Combination of Elotuzumab and Lenalidomide +/- Dexamethasone in High-Risk Smoldering Multiple Myeloma Dana-Farber Cancer Institute Recruiting
2
Trial Phase
82
Trial Size
1.29 1 miles
Phase II Study of Tipifarnib in Advanced Cancers With HRAS Mutations Kura Oncology, Inc. Recruiting
2
Trial Phase
36
Trial Size
1.29 1 miles
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan Brigham and Women's Hospital Recruiting N/A
35
Trial Size
1.29 1 miles
A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma BioClin Therapeutics, Inc. Recruiting
2
Trial Phase
211
Trial Size
1.29 1 miles
Study of Vitamin D in Untreated Metastatic Colorectal Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
120
Trial Size
1.29 1 miles
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Halozyme Therapeutics Recruiting
2
Trial Phase
237
Trial Size
1.29 1 miles
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
500
Trial Size
1.29 1 miles
HIV Non-Occupational Post-Exposure Prophylaxis Fenway Community Health Recruiting
4
Trial Phase
120
Trial Size
1.29 1 miles
A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures University of Michigan Recruiting
3
Trial Phase
623
Trial Size
1.29 1 miles
Outcomes of a Deep Inferior Epigastric Perforator Flap Program Beth Israel Deaconess Medical Center Recruiting N/A
2400
Trial Size
1.29 1 miles
Early patient access single named patient program for the use of ulocuplumab for the treatment of multiple myeloma Dana-Farber Cancer Institute Available N/A
0
Trial Size
1.29 1 miles
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors Novartis Recruiting
1
Trial Phase
105
Trial Size
1.29 1 miles
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
27
Trial Size
1.29 1 miles
Axicabtagene Ciloleucel Expanded Access Study Kite Pharma, Inc. Available N/A
0
Trial Size
1.29 1 miles
Acute Kidney Injury Standardized Clinical Assessment and Management Plan for Renal Replacement Initiation Brigham and Women's Hospital Recruiting N/A
160
Trial Size
1.29 1 miles
mHealth Intervention for Older Adults Boston College Recruiting N/A
10
Trial Size
1.29 1 miles
JASPER Early Intervention for Tuberous Sclerosis University of California, Los Angeles Recruiting N/A
64
Trial Size
1.29 1 miles
Genomic Determinants and Shared Genetic Pathways of Periodontal Disease Tufts University Recruiting N/A
360
Trial Size
1.29 1 miles
Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes Joslin Diabetes Center Recruiting N/A
60
Trial Size
1.29 1 miles
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System Joslin Diabetes Center Recruiting N/A
200
Trial Size
1.29 1 miles
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting
1
Trial Phase
36
Trial Size
1.29 1 miles
Clinical Trial of SP-2577 in Patients With Relapsed or Refractory Ewing Sarcoma Salarius Pharmaceuticals, LLC Recruiting
1
Trial Phase
50
Trial Size
1.29 1 miles
Testing Psychosocial Treatment Planning Methods for Youth Anxiety and Depression Boston University Charles River Campus Recruiting N/A
52
Trial Size
1.29 1 miles
Brentuximab Vedotin and Nivolumab in Treating Participants With Early Stage Classic Hodgkin Lymphoma City of Hope Medical Center Recruiting
2
Trial Phase
264
Trial Size
1.29 1 miles
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia Clear Creek Bio, Inc. Recruiting
1
Trial Phase
27
Trial Size
1.29 1 miles
Improving Safety of Transitions to Skilled Nursing Care Using Videoconferencing Beth Israel Deaconess Medical Center Recruiting N/A
20
Trial Size
1.29 1 miles
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use Fenway Community Health Recruiting
4
Trial Phase
15
Trial Size
1.29 1 miles
Wellness Tool in Anesthesia Providers Beth Israel Deaconess Medical Center Recruiting N/A
108
Trial Size
1.29 1 miles
Investigation of 2X-121 in Patients With Advanced Ovarian Cancer Selected by the 2X-121 DRP® Oncology Venture Recruiting
2
Trial Phase
60
Trial Size
1.29 1 miles
3D Printer Modified CPAP Mask for Obstructive Sleep Apnea Beth Israel Deaconess Medical Center Recruiting N/A
20
Trial Size
1.29 1 miles
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC Odonate Therapeutics, Inc. Recruiting
2
Trial Phase
130
Trial Size
1.29 1 miles
Internet-based Videoconferencing to Address Alcohol Use and Pain Boston University Charles River Campus Recruiting N/A
8
Trial Size
1.29 1 miles
Pulmonary Hemodynamics During Exercise - Research Network Medical University of Graz Recruiting N/A
1500
Trial Size
1.61 2 miles
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients APT Pharmaceuticals, Inc. Available N/A
0
Trial Size
1.65 2 miles
Double Cord Versus Haploidentical (BMT CTN 1101) Medical College of Wisconsin Recruiting
3
Trial Phase
410
Trial Size
1.65 2 miles
Brentuximab Vedotin for Steroid Refractory GvHD Massachusetts General Hospital Recruiting
1
Trial Phase
28
Trial Size
1.65 2 miles
A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001 Seattle Genetics, Inc. Available N/A
0
Trial Size
1.65 2 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
1.65 2 miles
School Inner-City Asthma Intervention Study (SICAS-2) Children's Hospital Boston Recruiting
4
Trial Phase
300
Trial Size
1.65 2 miles
Prevention of Phantom Limb Pain After Transtibial Amputation Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting N/A
400
Trial Size
1.65 2 miles
Eevaâ„¢ Pregnancy Pilot Study (PPS) Auxogyn, Inc. Recruiting N/A
240
Trial Size
1.65 2 miles
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma National Cancer Institute (NCI) Recruiting
2
Trial Phase
160
Trial Size
1.65 2 miles
Longitudinal Study of Urea Cycle Disorders Office of Rare Diseases (ORD) Recruiting
2
Trial Phase
1100
Trial Size
1.65 2 miles
Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia Children's Hospital Boston Recruiting N/A
20
Trial Size
1.65 2 miles
A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM) Audentes Therapeutics Recruiting N/A
100
Trial Size
1.65 2 miles
Patient-Centered Care for the Older Adult With Hematologic Malignancy Dana-Farber Cancer Institute Recruiting N/A
162
Trial Size
1.65 2 miles
Evaluation of the Duration of Therapy for Thrombosis in Children University of Colorado, Denver Recruiting
3
Trial Phase
750
Trial Size
1.65 2 miles
Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure Duke University Recruiting
3
Trial Phase
220
Trial Size
1.65 2 miles
Imputation of PaO2 From SaO2 Brigham and Women's Hospital Recruiting N/A
1000
Trial Size
1.65 2 miles
Low Dose IL-2 for Ulcerative Colitis Children's Hospital Boston Recruiting
1
Trial Phase
28
Trial Size
1.65 2 miles
Assessment of Fluoroscopy Times With Surgeon Versus Technologist Control Children's Hospital Boston Recruiting N/A
150
Trial Size
1.65 2 miles
Examination of Balance, Vestibular, and Ocular Functions and Activity Following Concussion Children's Hospital Boston Recruiting N/A
60
Trial Size
1.65 2 miles
The Effects of Head Trauma on Collegiate Athletes Children's Hospital Boston Recruiting N/A
250
Trial Size
1.65 2 miles
LED Therapy for the Treatment of Concussive Brain Injury Children's Hospital Boston Recruiting N/A
48
Trial Size
1.65 2 miles
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer Academic and Community Cancer Research United Recruiting
2
Trial Phase
200
Trial Size
1.65 2 miles
Regional Distribution Differences Between Neurally Adjusted Ventilatory Assist and Pressure Support Ventilation Children's Hospital Boston Recruiting N/A
25
Trial Size
1.65 2 miles
A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients Dana-Farber Cancer Institute Recruiting N/A
40
Trial Size
1.65 2 miles
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma Ann & Robert H Lurie Children's Hospital of Chicago Recruiting
3
Trial Phase
160
Trial Size
1.65 2 miles
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer Dana-Farber Cancer Institute Recruiting
1
Trial Phase
114
Trial Size
1.65 2 miles
The Women's Health Study: From Adolescence to Adulthood Children's Hospital Boston Recruiting N/A
2000
Trial Size
1.65 2 miles
Artisan Aphakia Lens for the Correction of Aphakia in Children Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
1.65 2 miles
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors InSightec Recruiting
1
Trial Phase
10
Trial Size
1.65 2 miles
Dominantly Inherited Alzheimer Network (DIAN) Washington University School of Medicine Recruiting N/A
400
Trial Size
1.65 2 miles
SVRII Family Factors Study Medical College of Wisconsin Recruiting N/A
250
Trial Size
1.65 2 miles
Focal MR-Guided Focused Ultrasound Treatment of Localized Low and Intermediate Risk Prostate Cancer InSightec Recruiting
1
Trial Phase
40
Trial Size
1.65 2 miles
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study Brigham and Women's Hospital Recruiting N/A
30
Trial Size
1.65 2 miles
Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire Brigham and Women's Hospital Recruiting N/A
70
Trial Size
1.65 2 miles
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Vanderbilt-Ingram Cancer Center Recruiting
1
Trial Phase
74
Trial Size
1.65 2 miles
A Study to Assess the Efficacy and Safety of IONIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy Isis Pharmaceuticals Recruiting
3
Trial Phase
117
Trial Size
1.65 2 miles
PKU Kuvan Imaging Study Children's Hospital Boston Recruiting N/A
12
Trial Size
1.65 2 miles
Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract Dana-Farber Cancer Institute Recruiting
2
Trial Phase
30
Trial Size
1.65 2 miles
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Center for International Blood and Marrow Transplant Research Recruiting
3
Trial Phase
35000
Trial Size
1.65 2 miles
Genes and Environment in Multiple Sclerosis Brigham and Women's Hospital Recruiting N/A
5000
Trial Size
1.65 2 miles
Short-term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia Children's Research Institute Recruiting
2
Trial Phase
144
Trial Size
1.65 2 miles
A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy Marinus Pharmaceuticals Recruiting
2
Trial Phase
20
Trial Size
1.65 2 miles
Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis Beth Israel Deaconess Medical Center Recruiting N/A
38
Trial Size
1.65 2 miles
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) Harvard School of Public Health Recruiting N/A
850
Trial Size
1.65 2 miles
High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull Massachusetts General Hospital Recruiting
2
Trial Phase
120
Trial Size
1.65 2 miles
Proton or Photon RT for Retroperitoneal Sarcomas Massachusetts General Hospital Recruiting
1
Trial Phase
80
Trial Size
1.65 2 miles
Cisplatin + RT for Triple Negative Breast Cancer Dana-Farber Cancer Institute Recruiting
1
Trial Phase
39
Trial Size
1.65 2 miles
Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks Dana-Farber Cancer Institute Recruiting
3
Trial Phase
625
Trial Size
1.65 2 miles
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure Duke University Recruiting
2
Trial Phase
360
Trial Size
1.65 2 miles
Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention Dana-Farber Cancer Institute Recruiting N/A
75
Trial Size
1.65 2 miles
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture Dana-Farber Cancer Institute Recruiting N/A
30
Trial Size
1.65 2 miles
Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer Novartis Recruiting
1
Trial Phase
78
Trial Size
1.65 2 miles
Stress and the Nervous System Brigham and Women's Hospital Recruiting N/A
60
Trial Size
1.65 2 miles
Genomic Sequencing for Childhood Risk and Newborn Illness Brigham and Women's Hospital Recruiting N/A
1440
Trial Size
1.65 2 miles
Molecular and Genetic Studies of Congenital Myopathies Children's Hospital Boston Recruiting N/A
4000
Trial Size
1.65 2 miles
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors ImmunoGen, Inc. Recruiting
1
Trial Phase
205
Trial Size
1.65 2 miles
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection AIDS Clinical Trials Group Recruiting
1
Trial Phase
50
Trial Size
1.65 2 miles
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study Vanderbilt University Recruiting
3
Trial Phase
561
Trial Size
1.65 2 miles
Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients Brigham and Women's Hospital Recruiting N/A
85
Trial Size
1.65 2 miles
Heart And Lung Failure - Pediatric INsulin Titration Trial Children's Hospital Boston Recruiting
3
Trial Phase
1414
Trial Size
1.65 2 miles
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma National Cancer Institute (NCI) Recruiting
1
Trial Phase
62
Trial Size
1.65 2 miles
Estimating Apnea Phenotypes From Polysomnography: Oxygen Brigham and Women's Hospital Recruiting N/A
30
Trial Size
1.65 2 miles
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B University of Pittsburgh Recruiting N/A
300
Trial Size
1.65 2 miles
Preeclampsia: A Marker for Future Cardiovascular Risk in Women Brigham and Women's Hospital Recruiting N/A
150
Trial Size
1.65 2 miles
Study to Identify Transcriptional Targets of Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases Receiving Preoperative Vitamin D Supplementation. Dana-Farber Cancer Institute Recruiting
0
Trial Phase
12
Trial Size
1.65 2 miles
Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide Children's Hospital Boston Recruiting
1
Trial Phase
50
Trial Size
1.65 2 miles
Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients Brigham and Women's Hospital Recruiting N/A
200
Trial Size
1.65 2 miles
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression) Brigham and Women's Hospital Recruiting N/A
200
Trial Size
1.65 2 miles
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study National Heart, Lung, and Blood Institute (NHLBI) Recruiting N/A
2000
Trial Size
1.65 2 miles
Genetic Mechanisms in Human Hypertension Brigham and Women's Hospital Recruiting N/A
1000
Trial Size
1.65 2 miles
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction Brigham and Women's Hospital Recruiting N/A
20
Trial Size
1.65 2 miles
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine Brigham and Women's Hospital Recruiting N/A
50
Trial Size
1.65 2 miles
COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Brigham and Women's Hospital Recruiting
2
Trial Phase
12
Trial Size
1.65 2 miles
Functional Applications of Hyperpolarized 129Xe MRI Brigham and Women's Hospital Recruiting
1
Trial Phase
100
Trial Size
1.65 2 miles
Genetic and Environmental Risk Factors Related to Esophageal Cancer National Cancer Institute (NCI) Recruiting N/A
1200
Trial Size
1.65 2 miles
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy Marathon Pharmaceuticals, LLC Available N/A
0
Trial Size
1.65 2 miles
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors Genentech, Inc. Available N/A
0
Trial Size
1.65 2 miles
PREG-MS: New England MS Pregnancy Registry Brigham and Women's Hospital Recruiting N/A
500
Trial Size
1.65 2 miles
Hypoglycemia and Autonomic Nervous System Function- B2 Brigham and Women's Hospital Recruiting N/A
14
Trial Size
1.65 2 miles
Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT Hummingbird Diagnostics Recruiting N/A
400
Trial Size
1.65 2 miles
Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2 Brigham and Women's Hospital Recruiting N/A
24
Trial Size
1.65 2 miles
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension AB2 Bio Ltd. Recruiting
3
Trial Phase
10
Trial Size
1.65 2 miles
Home Hospital for Suddenly Ill Adults Brigham and Women's Hospital Recruiting N/A
500
Trial Size
1.65 2 miles
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
1.65 2 miles
Chemotherapy and/or Metastasectomy in Treating Participants With Metastatic Colorectal Adenocarcinoma With Lung Metastases M.D. Anderson Cancer Center Recruiting
2
Trial Phase
365
Trial Size
1.65 2 miles
Multi-modal Neuroimaging in Children With Cerebral Palsy or Brachial Plexus Birth Palsy Boston Children’s Hospital Recruiting N/A
90
Trial Size
1.65 2 miles
Integrated Approaches to Health and Safety in a Dynamic Construction Work Environment Harvard School of Public Health Recruiting N/A
500
Trial Size
1.65 2 miles
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS Zynerba Pharmaceuticals, Inc. Recruiting
2
Trial Phase
300
Trial Size
1.65 2 miles
ATHN 8: PUPs Matter Study American Thrombosis and Hemostasis Network Recruiting N/A
250
Trial Size
1.65 2 miles
REtroperitoneal SArcoma Registry: an International Prospective Initiative Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting N/A
2000
Trial Size
1.65 2 miles
Treatment of Persistent Cough in IPF With Inhaled RVT-1601 Respivant Sciences Inc. Recruiting
2
Trial Phase
180
Trial Size
1.65 2 miles
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Columbia University Recruiting N/A
30
Trial Size
1.65 2 miles
Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain Dana-Farber Cancer Institute Recruiting N/A
10
Trial Size
1.65 2 miles
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer Dana-Farber Cancer Institute Recruiting N/A
10
Trial Size
1.65 2 miles
Microdevice for Evaluating Drug Response in Site in Lung Lesions Brigham and Women's Hospital Recruiting
1
Trial Phase
5
Trial Size
1.65 2 miles
Sebacia Postmarket Study of Real-World Use Sebacia, Inc. Recruiting N/A
125
Trial Size
1.95 2 miles
Cystic Fibrosis Related Bone Disease: the Role of CFTR Massachusetts General Hospital Recruiting N/A
90
Trial Size
1.96 2 miles
Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy Massachusetts Eye and Ear Infirmary Recruiting
2
Trial Phase
722
Trial Size
1.96 2 miles
Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder Massachusetts General Hospital Recruiting N/A
60
Trial Size
1.96 2 miles
Trial of Verapamil in Chronic Rhinosinusitis Massachusetts Eye and Ear Infirmary Recruiting N/A
158
Trial Size
1.96 2 miles
L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults Massachusetts General Hospital Recruiting
2
Trial Phase
40
Trial Size
1.96 2 miles
Cabozantinib in Advanced Solid Malignancies Massachusetts General Hospital Recruiting
2
Trial Phase
29
Trial Size
1.96 2 miles
A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV Massachusetts General Hospital Recruiting
2
Trial Phase
60
Trial Size
1.96 2 miles
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones Mayo Clinic Recruiting N/A
150
Trial Size
1.96 2 miles
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) Neurotech Pharmaceuticals Recruiting
1
Trial Phase
170
Trial Size
1.96 2 miles
Oral TRK Inhibitor LOXO-101 for Treatment of Advanced Adult Solid Tumors Loxo Oncology, Inc. Recruiting
1
Trial Phase
108
Trial Size
1.96 2 miles
Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Avid Radiopharmaceuticals Recruiting
2
Trial Phase
1800
Trial Size
1.96 2 miles
SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) Biotie Therapies Inc. Recruiting
2
Trial Phase
80
Trial Size
1.96 2 miles
Short-Term Oral Mifepristone for Central Serous Chorioretinopathy Bay Area Retina Associates Recruiting
2
Trial Phase
30
Trial Size
1.96 2 miles
Phase I/II Study of PDR001 in Patients With Advanced Malignancies Novartis Recruiting
1
Trial Phase
180
Trial Size
1.96 2 miles
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia National Cancer Institute (NCI) Recruiting
3
Trial Phase
4895
Trial Size
1.96 2 miles
Omega-3 Supplementation to ADHD Medication in Children Massachusetts General Hospital Recruiting
4
Trial Phase
20
Trial Size
1.96 2 miles
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Massachusetts General Hospital Recruiting
2
Trial Phase
30
Trial Size
1.96 2 miles
In-Room PET in Proton Radiation Therapy Massachusetts General Hospital Recruiting
0
Trial Phase
39
Trial Size
1.96 2 miles
Proton Radiation Therapy for Gliomas Massachusetts General Hospital Recruiting
2
Trial Phase
50
Trial Size
1.96 2 miles
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery National Cancer Institute (NCI) Recruiting N/A
45
Trial Size
1.96 2 miles
Answer ALS: Individualized Initiative for ALS Discovery Johns Hopkins University Recruiting N/A
1000
Trial Size
1.96 2 miles
PET/CT Imaging Companion Study To ACTG A5314 Massachusetts General Hospital Recruiting
2
Trial Phase
91
Trial Size
1.96 2 miles
Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer Massachusetts General Hospital Recruiting
2
Trial Phase
50
Trial Size
1.96 2 miles
FOLFIRINOX + RT for Pancreatic Cancer Massachusetts General Hospital Recruiting
2
Trial Phase
50
Trial Size
1.96 2 miles
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer Novartis Recruiting
1
Trial Phase
142
Trial Size
1.96 2 miles
Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma Massachusetts General Hospital Recruiting
0
Trial Phase
25
Trial Size
1.96 2 miles
Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema Eyegate Pharmaceuticals, Inc. Recruiting
1
Trial Phase
20
Trial Size
1.96 2 miles
A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia Massachusetts General Hospital Recruiting
2
Trial Phase
60
Trial Size
1.96 2 miles
The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma Georgetown University Recruiting
2
Trial Phase
15
Trial Size
1.96 2 miles
Evaluation of Cardiopulmonary Diseases by Ultrasound Echosense Ltd. Recruiting N/A
600
Trial Size
1.96 2 miles
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Novartis Recruiting
1
Trial Phase
100
Trial Size
1.96 2 miles
ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators Massachusetts General Hospital Recruiting N/A
60
Trial Size
1.96 2 miles
Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies Massachusetts General Hospital Recruiting N/A
25
Trial Size
1.96 2 miles
Metformin Treatment in Polycystic Ovary Syndrome (PCOS) Massachusetts General Hospital Recruiting N/A
20
Trial Size
1.96 2 miles
Modifying the Workplace to Decrease Sedentary Behavior and Improve Health Northeastern University Recruiting N/A
66
Trial Size
1.96 2 miles
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung ACORN Research, LLC Recruiting
2
Trial Phase
35
Trial Size
1.96 2 miles
Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device Carticept Medical, Inc Recruiting N/A
120
Trial Size
1.96 2 miles
Evaluating the Effect of Acupuncture on Pain Relief Using Quantitative Sensory Testing (QST) Massachusetts General Hospital Recruiting N/A
150
Trial Size
1.96 2 miles
Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease Massachusetts General Hospital Recruiting N/A
10
Trial Size
1.96 2 miles
Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study Massachusetts General Hospital Recruiting N/A
60
Trial Size
1.96 2 miles
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects HumanOptics AG Recruiting
3
Trial Phase
460
Trial Size
1.96 2 miles
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated in the DALF-PS-1016 Study Acorda Therapeutics Recruiting
3
Trial Phase
100
Trial Size
1.96 2 miles
Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum Massachusetts General Hospital Recruiting
1
Trial Phase
50
Trial Size
1.96 2 miles
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Novartis Available N/A
0
Trial Size
1.96 2 miles
Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients Massachusetts Eye and Ear Infirmary Available N/A
0
Trial Size
1.96 2 miles
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients Massachusetts General Hospital Recruiting N/A
20
Trial Size
1.96 2 miles
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) Astellas Pharma Inc Available N/A
0
Trial Size
1.96 2 miles
A Text Messaging Program for Smokers in Primary Care Massachusetts General Hospital Recruiting
4
Trial Phase
206
Trial Size
1.96 2 miles
ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) Ophthotech Corporation Recruiting
2
Trial Phase
60
Trial Size
1.96 2 miles
Natural History Study of CEP290-Related Retinal Degeneration Editas Medicine, Inc. Recruiting N/A
40
Trial Size
1.96 2 miles
Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders Massachusetts General Hospital Recruiting N/A
49
Trial Size
1.96 2 miles
A Study of VB-111 Combined With Paclitaxel vs. Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) Vascular Biogenics Ltd. operating as VBL Therapeutics Recruiting
3
Trial Phase
350
Trial Size
1.96 2 miles
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing Massachusetts General Hospital Recruiting N/A
224
Trial Size
1.96 2 miles
Depression and Body Image Distress Following Mastectomy With Reconstruction Massachusetts General Hospital Recruiting N/A
49
Trial Size
1.96 2 miles
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150] Hoffmann-La Roche Recruiting
3
Trial Phase
480
Trial Size
1.96 2 miles
SMART Program for Paroxysmal Atrial Fibrillation Massachusetts General Hospital Recruiting N/A
18
Trial Size
1.96 2 miles
The Effect of RNS60 on ALS Biomarkers Mario Negri Institute for Pharmacological Research Recruiting
2
Trial Phase
142
Trial Size
1.96 2 miles
Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy Massachusetts General Hospital Recruiting N/A
500
Trial Size
1.96 2 miles
Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome Massachusetts General Hospital Recruiting N/A
2000
Trial Size
1.96 2 miles
Retention in HIV Care for Hispanic Immigrants Massachusetts General Hospital Recruiting N/A
70
Trial Size
1.96 2 miles
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease Cour Pharmaceutical Development Company, Inc. Recruiting
1
Trial Phase
22
Trial Size
1.96 2 miles
Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients Midatech Pharma US Inc. Recruiting
4
Trial Phase
60
Trial Size
1.96 2 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
1.96 2 miles
Treatments for Anxiety: Meditation and Escitalopram Georgetown University Recruiting
4
Trial Phase
370
Trial Size
1.96 2 miles
Brexpiprazole Study University of Massachusetts, Worcester Recruiting
4
Trial Phase
80
Trial Size
1.96 2 miles
Does Use of Rapid Response EEG Impact Clinical Decision Making Ceribell Inc. Recruiting N/A
200
Trial Size
1.96 2 miles
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy Hoffmann-La Roche Recruiting
2
Trial Phase
100
Trial Size
1.96 2 miles
Collection of Breath and Sweat to Identify Indicators of Hypoglycemia Massachusetts General Hospital Recruiting
2
Trial Phase
24
Trial Size
1.96 2 miles
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis University of Iowa Recruiting N/A
860
Trial Size
1.96 2 miles
Photobiomodulation in Autism Spectrum Disorder (ASD) Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study Massachusetts General Hospital Recruiting N/A
210
Trial Size
1.96 2 miles
Myocardial Infarction, COmbined-device, Recovery Enhancement Study Johns Hopkins University Recruiting N/A
950
Trial Size
1.96 2 miles
Pilocarpine and Brimonidine in Patients With Monofocal Lenses Massachusetts Eye and Ear Infirmary Recruiting
1
Trial Phase
33
Trial Size
1.96 2 miles
Growth Hormone Dynamics and Cardiac Steatosis in HIV Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder Massachusetts General Hospital Recruiting N/A
500
Trial Size
1.96 2 miles
Imaging of LAA Thrombosis Massachusetts General Hospital Recruiting
1
Trial Phase
100
Trial Size
1.96 2 miles
MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms Massachusetts General Hospital Recruiting N/A
70
Trial Size
1.96 2 miles
A Phase 1 Clinical Trial of ARV-110 in Patients With Metastatic Castration-resistant Prostate Cancer. Arvinas Inc Recruiting
1
Trial Phase
36
Trial Size
1.96 2 miles
BMAC Use With Labral Repair Massachusetts General Hospital Recruiting N/A
40
Trial Size
1.96 2 miles
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum Massachusetts General Hospital Recruiting N/A
80
Trial Size
1.96 2 miles
Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds Rogers Sciences Inc. Recruiting N/A
12
Trial Size
1.96 2 miles
VX15/2503 Treatment for Huntington's Disease Vaccinex Inc. Recruiting
2
Trial Phase
84
Trial Size
2.00 2 miles
Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia Brigham and Women's Hospital Recruiting N/A
200
Trial Size
2.00 2 miles
Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Spinal Cord Injury Patients Spaulding Rehabilitation Hospital Recruiting
2
Trial Phase
60
Trial Size
2.00 2 miles
Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis University of Pittsburgh Recruiting
2
Trial Phase
40
Trial Size
2.41 2 miles
Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access Biomet, Inc. Available N/A
0
Trial Size
2.41 2 miles
Healthy Families Healthy Forces Study Tufts University Recruiting N/A
580
Trial Size
2.41 2 miles
Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL Affimed Therapeutics AG Recruiting
1
Trial Phase
50
Trial Size
2.41 2 miles
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Reata Pharmaceuticals, Inc. Recruiting
2
Trial Phase
210
Trial Size
2.41 2 miles
The TCF7L2 Gene: Dietary Prevention of T2DM Tufts University Recruiting N/A
40
Trial Size
2.41 2 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
2.41 2 miles
Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study Tufts Medical Center Recruiting N/A
30
Trial Size
2.41 2 miles
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer Massachusetts General Hospital Recruiting
2
Trial Phase
32
Trial Size
2.44 2 miles
Development of an Intervention to Enhance Cancer Pain Management Massachusetts General Hospital Recruiting N/A
150
Trial Size
2.44 2 miles
Collecting Samples From Patients With Primary Systemic Amyloidosis Boston Medical Center Recruiting N/A
10000
Trial Size
2.85 3 miles
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis Academic Myeloma Consortium Recruiting
1
Trial Phase
42
Trial Size
2.85 3 miles
Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection National Cancer Institute (NCI) Recruiting
1
Trial Phase
26
Trial Size
2.85 3 miles
Scleroderma Treatment With Autologous Transplant (STAT) Study Fred Hutchinson Cancer Research Center Recruiting
2
Trial Phase
30
Trial Size
2.85 3 miles
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Southwest Oncology Group Recruiting
3
Trial Phase
1900
Trial Size
2.85 3 miles
Real Talk Brief Intervention Study Boston University Recruiting
1
Trial Phase
360
Trial Size
2.85 3 miles
Linking Former Inmates to Primary Care Yale University Recruiting N/A
2000
Trial Size
2.85 3 miles
Reducing Socioeconomic Disparities in Health at Pediatric Visits Boston Medical Center Recruiting N/A
2050
Trial Size
2.85 3 miles
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor Sera Prognostics, Inc. Recruiting N/A
4000
Trial Size
2.85 3 miles
ATTR Expanded Access Program (EAP) by Ionis Ionis Pharmaceuticals, Inc. Available N/A
0
Trial Size
2.85 3 miles
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Genentech, Inc. Recruiting
2
Trial Phase
240
Trial Size
2.85 3 miles
Growing Together: Women in Opioid Treatment and Their Infants Boston University Charles River Campus Recruiting N/A
100
Trial Size
2.85 3 miles
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension Allergan Recruiting
3
Trial Phase
600
Trial Size
3.95 4 miles
Innovative Methods to Assess Psychotherapy Practices (imAPP) Palo Alto Veterans Institute for Research Recruiting N/A
480
Trial Size
3.95 4 miles
North American Prodromal Synucleinopathy Consortium Washington University School of Medicine Recruiting N/A
300
Trial Size
3.95 4 miles
Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers Osiris Therapeutics Recruiting N/A
200
Trial Size
3.95 4 miles
A Study of MTAU9937A in Patients With Moderate Alzheimer's Disease Genentech, Inc. Recruiting
2
Trial Phase
260
Trial Size
3.95 4 miles
Forms of Racial Discrimination Study University of Massachusetts, Boston Recruiting N/A
100
Trial Size
4.02 4 miles
Epilepsy Birth Control Registry Neuroendocrine Associates P.C. Recruiting N/A
1000
Trial Size
4.19 4 miles
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia Mclean Hospital Recruiting
2
Trial Phase
18
Trial Size
4.19 4 miles
D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation (DCS) Mclean Hospital Recruiting
1
Trial Phase
40
Trial Size
4.19 4 miles
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) Radius Health, Inc. Recruiting
3
Trial Phase
225
Trial Size
4.19 4 miles
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Pulse Biosciences, Inc. Recruiting N/A
75
Trial Size
4.19 4 miles
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
300
Trial Size
4.19 4 miles
Together we Move: A Multi-component Intervention to Increase Physical Activity for Ethnic Minority Older Adults Boston College Recruiting N/A
60
Trial Size
4.19 4 miles
Attention to Variability During Infertility Harvard University Recruiting N/A
160
Trial Size
4.19 4 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
4.19 4 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
4.19 4 miles
Walking Competition to Enhance Daily Physical Activity and Social Engagement Among Older Adults Brandeis University Recruiting N/A
64
Trial Size
4.19 4 miles
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) Urovant Sciences GmbH Recruiting
3
Trial Phase
1088
Trial Size
4.19 4 miles
Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2) ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
280
Trial Size
4.19 4 miles
Group CBT for PTSD Department of Veterans Affairs Recruiting
2
Trial Phase
196
Trial Size
5.04 5 miles
Written Exposure Therapy for Posttraumatic Stress Disorder Boston University Recruiting
2
Trial Phase
126
Trial Size
5.04 5 miles
Telemedicine Intervention to Improve Cognitive Function Department of Veterans Affairs Recruiting
3
Trial Phase
128
Trial Size
5.04 5 miles
LED Treatment to Improve Cognition and Promote Recovery in TBI Department of Veterans Affairs Recruiting
2
Trial Phase
32
Trial Size
5.04 5 miles
Oxygen Versus PAP for Treatment of Sleep Apnea in Chronic Heart Failure Department of Veterans Affairs Recruiting
4
Trial Phase
161
Trial Size
5.04 5 miles
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit VA Office of Research and Development Recruiting N/A
100
Trial Size
5.04 5 miles
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US Bio-Medical Research, Ltd. Recruiting N/A
180
Trial Size
5.66 6 miles
AGN-241751 in the Treatment of Major Depressive Disorder Allergan Recruiting
2
Trial Phase
250
Trial Size
5.66 6 miles
Multi-Center Study of Sensory Stimulation to Improve Brain Function Cognito Therapeutics, Inc. Recruiting N/A
60
Trial Size
8.70 9 miles
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) University of California, Los Angeles Recruiting N/A
710
Trial Size
10.80 11 miles
Usability and Performance Evaluation of the AutoLap System - a Feasibility Study M.S.T. Medical Surgery Technology LTD. Recruiting N/A
40
Trial Size
10.80 11 miles
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 Leading BioSciences, Inc Recruiting
2
Trial Phase
260
Trial Size
10.80 11 miles
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program Exact Sciences Corporation Recruiting N/A
1500
Trial Size
10.80 11 miles
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease Oyster Point Pharma, Inc. Recruiting
2
Trial Phase
160
Trial Size
19.79 20 miles
A Phase 3 Study of Reproxalap in Subjects With Allergic Conjunctivitis Aldeyra Therapeutics, Inc. Recruiting
3
Trial Phase
300
Trial Size
19.79 20 miles
A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (DED) AxeroVision, Inc. Recruiting
2
Trial Phase
430
Trial Size
19.79 20 miles
Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study) Oyster Point Pharma, Inc. Recruiting
2
Trial Phase
160
Trial Size
19.79 20 miles
A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease Aldeyra Therapeutics, Inc. Recruiting
2
Trial Phase
200
Trial Size
19.79 20 miles
True North, a research study for adults 18-75 with Ulcerative Colitis Celgene Recruiting
3
Trial Phase
900
Trial Size
20.06 20 miles
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Duke University Recruiting
2
Trial Phase
500
Trial Size
22.79 23 miles
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants Janssen Research & Development, LLC Recruiting
2
Trial Phase
440
Trial Size
22.79 23 miles
Experience With H.P. Acthar Gel Treatment of Patients With Nephrotic Syndrome/Proteinuria Due to Various Etiologies and Its Effect on Podocyte Function Greater Boston Medical Associates Recruiting N/A
40
Trial Size
26.14 26 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
26.14 26 miles
Vacuum Assisted Closure for Cesarean Section Dartmouth-Hitchcock Medical Center Recruiting
1
Trial Phase
400
Trial Size
32.89 33 miles
Endothelial Facilitation in Alzheimer's Disease University of Massachusetts, Worcester Recruiting
2
Trial Phase
10
Trial Size
34.02 34 miles
FORCE-TJR: Improving Orthopedic Outcomes Through a National TJR Registry University of Massachusetts, Worcester Recruiting N/A
30000
Trial Size
34.02 34 miles
Keeping Weight Off: Brain Changes Associated With Healthy Behaviors University of Massachusetts, Worcester Recruiting N/A
80
Trial Size
34.02 34 miles
POSITIVE Stroke Clinical Trial Medical University of South Carolina Recruiting N/A
750
Trial Size
34.02 34 miles
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation Astellas Pharma Inc Recruiting
3
Trial Phase
369
Trial Size
34.02 34 miles
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile University of Massachusetts, Worcester Recruiting N/A
500
Trial Size
34.02 34 miles
The Effect of Screen Time on Recovery From Concussion University of Massachusetts, Worcester Recruiting N/A
120
Trial Size
34.02 34 miles
Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation University of Massachusetts, Worcester Recruiting N/A
64
Trial Size
34.02 34 miles
Manually Operated Communication System University of Massachusetts, Worcester Recruiting N/A
20
Trial Size
34.02 34 miles
Evaluating Patient Satisfaction of UROGYN Office Visits With Different Type of Interpretation Services. University of Massachusetts, Worcester Recruiting N/A
114
Trial Size
35.72 36 miles
SAGE-AF Study Fibrillation (SAGE-AF) Study University of Massachusetts, Worcester Recruiting N/A
1200
Trial Size
35.72 36 miles
Older Adult Safety in Surgery (OASIS) IV University of Massachusetts, Worcester Recruiting N/A
200
Trial Size
35.72 36 miles
Connect® MM- The Multiple Myeloma Disease Registry Celgene Corporation Recruiting N/A
3000
Trial Size
36.34 36 miles
BrUOG 299 :Ixazomib, Oral Metronomic Cyclophosphamide and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study. Brown University Recruiting
2
Trial Phase
20
Trial Size
37.10 37 miles
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) Merck Recruiting
2
Trial Phase
1960
Trial Size
39.46 39 miles
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU Novartis Recruiting
2
Trial Phase
360
Trial Size
39.46 39 miles
Skills to Enhance Positive Affect in Suicidal Adolescents Brown University Recruiting N/A
70
Trial Size
39.46 39 miles
Adjunctive Psychotherapy for Perinatal Bipolar Disorder Brown University Recruiting N/A
52
Trial Size
39.46 39 miles
Healthy Expectations - A Program for Pregnant Women Experiencing Depressive Symptoms Butler Hospital Recruiting N/A
152
Trial Size
39.46 39 miles
Mobile After-Care Intervention to Support Post-Hospital Transition (MACS) Butler Hospital Recruiting N/A
10
Trial Size
39.46 39 miles
Rhode Island Diastolic Dysfunction - Heart Failure Providence VA Medical Center Recruiting N/A
30
Trial Size
39.90 40 miles
Home Study of an Advanced Upper Limb Prosthesis Department of Veterans Affairs Recruiting N/A
75
Trial Size
39.90 40 miles
Community Pharmacy Medication Therapy Management for Heart Failure Providence VA Medical Center Recruiting N/A
83
Trial Size
39.90 40 miles
Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases Sorrento Therapeutics, Inc. Recruiting
1
Trial Phase
6
Trial Size
39.90 40 miles
Quit Smoking With Nicotine Patch and Exercise/Health Education (Females Only) Brown University Recruiting
2
Trial Phase
164
Trial Size
40.36 40 miles
Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms Brown University Recruiting
1
Trial Phase
160
Trial Size
40.36 40 miles
Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media Brown University Recruiting N/A
164
Trial Size
40.36 40 miles
Development of Adaptive Deep Brain Stimulation for OCD Baylor College of Medicine Recruiting N/A
2
Trial Size
40.36 40 miles
Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial Brown University Recruiting N/A
12
Trial Size
40.36 40 miles
Positive Psychology for Physical Activity Promotion Brown University Recruiting N/A
60
Trial Size
40.36 40 miles
Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder Rhode Island Hospital Recruiting N/A
30
Trial Size
40.46 40 miles
Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls Bradley Hospital Recruiting N/A
240
Trial Size
40.46 40 miles
Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community Brown University Recruiting N/A
60
Trial Size
40.46 40 miles
Neurobiology of Psychogenic Movement Disorder and Non-Epileptic Seizures National Institutes of Health Clinical Center (CC) Recruiting N/A
305
Trial Size
40.82 41 miles
Smoking Cessation Intervention for Diabetic Patients Rhode Island Hospital Recruiting
1
Trial Phase
72
Trial Size
40.82 41 miles
A Study of LY2801653 in Advanced Cancer Eli Lilly and Company Recruiting
1
Trial Phase
190
Trial Size
40.82 41 miles
Text-Message-Based Depression Prevention for High-Risk Youth in the ED Rhode Island Hospital Recruiting N/A
100
Trial Size
40.82 41 miles
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 GlaxoSmithKline Recruiting
1
Trial Phase
80
Trial Size
40.82 41 miles
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy National Cancer Institute (NCI) Recruiting
1
Trial Phase
30
Trial Size
40.82 41 miles
Bullying Prevention Intervention for Adolescent Primary Care Patients Rhode Island Hospital Recruiting N/A
50
Trial Size
40.82 41 miles
Rolandic Epilepsy Genomewide Association International Study King's College London Recruiting N/A
3000
Trial Size
40.82 41 miles
Assessing Tobacco Product Choice When the Cost of Menthol Cigarettes Increases Brown University Recruiting N/A
60
Trial Size
40.82 41 miles
Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents Rhode Island Hospital Recruiting N/A
800
Trial Size
40.82 41 miles
Oral vs Intravesical Analgesia for Office Bladder Botox Injections Women and Infants Hospital of Rhode Island Recruiting
4
Trial Phase
110
Trial Size
40.82 41 miles
Evaluation of microMend Device to Close Lacerations KitoTech Medical, Inc. Recruiting N/A
30
Trial Size
40.82 41 miles
Novel Digital Health Intervention to Promote Engagement in and Adherence to Medication-Assisted Treatment. Rhode Island Hospital Recruiting
1
Trial Phase
60
Trial Size
40.82 41 miles
Project CORE: Disseminating Eating Disorders Treatment The Miriam Hospital Recruiting
1
Trial Phase
20
Trial Size
40.82 41 miles
Text-based Alcohol Prevention for First Year College Students Brown University Recruiting N/A
120
Trial Size
40.82 41 miles
Passive Sensing Technology for Lapse Measurement The Miriam Hospital Recruiting N/A
40
Trial Size
41.73 42 miles
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
800
Trial Size
42.45 42 miles
Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates Draeger Medical Systems, Inc. Recruiting N/A
225
Trial Size
42.45 42 miles
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse Acorda Therapeutics Recruiting
1
Trial Phase
30
Trial Size
42.45 42 miles
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Menlo Therapeutics Inc. Recruiting
3
Trial Phase
400
Trial Size
42.86 43 miles
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Menlo Therapeutics Inc. Recruiting
3
Trial Phase
200
Trial Size
42.86 43 miles
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain ObsEva SA Recruiting
3
Trial Phase
450
Trial Size
44.76 45 miles
Understanding How Cognitive Remediation Works Boston University Recruiting N/A
244
Trial Size
44.94 45 miles
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
37
Trial Size
47.01 47 miles
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
3
Trial Phase
1800
Trial Size
47.01 47 miles
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Shire Recruiting
3
Trial Phase
264
Trial Size
48.97 49 miles
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery KV Pharmaceutical Company Recruiting
3
Trial Phase
1707
Trial Size
51.13 51 miles
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) ImmusanT, Inc. Recruiting
2
Trial Phase
146
Trial Size
56.78 57 miles
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma Celgene Corporation Available N/A
0
Trial Size
64.44 64 miles
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia Pharmacyclics Recruiting N/A
1500
Trial Size
64.44 64 miles
Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant University of California, Los Angeles Recruiting N/A
900
Trial Size
64.72 65 miles
Targeted Food Incentives to Improve Diet Quality and Health Among Adults University of Rhode Island Recruiting N/A
225
Trial Size
64.72 65 miles
Easytech Reversed Shoulder System Clinical Study FX Shoulder USA, Inc. Recruiting N/A
90
Trial Size
68.75 69 miles
Cadence and Intensity in Adults With Type 2 Diabetes University of Massachusetts, Amherst Recruiting N/A
20
Trial Size
69.66 70 miles
Development of a Translational Tool to Study Yoga Therapy University of Connecticut Recruiting N/A
750
Trial Size
69.98 70 miles
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes BrainScope Company, Inc. Recruiting N/A
220
Trial Size
69.98 70 miles
The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups University of Connecticut Recruiting N/A
72
Trial Size
69.98 70 miles
Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement Intake University of Connecticut Recruiting N/A
25
Trial Size
69.98 70 miles
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma CASI Pharmaceuticals, Inc. Recruiting
2
Trial Phase
29
Trial Size
72.80 73 miles
Sex-specific Adaptation to Resistance Training in Older Adults University of Massachusetts, Amherst Recruiting N/A
50
Trial Size
72.80 73 miles
Sleep-dependent Learning in Aging University of Massachusetts, Amherst Recruiting N/A
584
Trial Size
72.80 73 miles
Addressing Mental Health Disparities in Refugee Children Boston College Recruiting N/A
1630
Trial Size
76.77 77 miles
Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors University of Rochester Recruiting
3
Trial Phase
422
Trial Size
76.93 77 miles
The MENDSII Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure Vanderbilt University Recruiting
3
Trial Phase
530
Trial Size
78.61 79 miles
Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery Baystate Medical Center Recruiting N/A
40
Trial Size
78.61 79 miles
Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room Baystate Medical Center Recruiting N/A
40
Trial Size
78.62 79 miles
A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES) Medtronic Surgical Technologies Recruiting N/A
1000
Trial Size
78.84 79 miles
Voice Treatment for Parkinson's Disease University of Massachusetts, Amherst Recruiting N/A
36
Trial Size
78.84 79 miles
RCT of the Restorative Practices Intervention RAND Recruiting N/A
2680
Trial Size
83.59 84 miles
Sildenafil in US Heart Failure Patients (SilHF-US) Hartford Hospital Recruiting
3
Trial Phase
25
Trial Size
90.45 90 miles
Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia Shionogi Inc. Recruiting
1
Trial Phase
18
Trial Size
90.45 90 miles
The Genetics of Severe Asthma in Children Connecticut Children's Medical Center Recruiting N/A
558
Trial Size
90.54 91 miles
What is the Impact of the Presence of a Support Person on Informed Consent Hartford Hospital Recruiting N/A
74
Trial Size
90.54 91 miles
Assessing Response to Albuterol in Bronchiolitis Connecticut Children's Medical Center Recruiting N/A
25
Trial Size
92.04 92 miles
The Genetics of Respiratory Failure in Bronchiolitis Connecticut Children's Medical Center Recruiting N/A
146
Trial Size
92.04 92 miles
Timing of Pessary Care Hartford Hospital Recruiting N/A
126
Trial Size
92.04 92 miles
Molecular-Guided Therapy for Childhood Cancer Spectrum Health Hospitals Recruiting N/A
56
Trial Size
92.04 92 miles
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
194
Trial Size
92.04 92 miles
Metformin in Children With Relapsed or Refractory Solid Tumors H. Lee Moffitt Cancer Center and Research Institute Recruiting
1
Trial Phase
25
Trial Size
92.04 92 miles
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease Hoffmann-La Roche Recruiting
1
Trial Phase
12
Trial Size
92.04 92 miles
Protein in Feeding Strategies to Accelerate Muscle Recovery From ACL Reconstruction University of Connecticut Recruiting N/A
20
Trial Size
92.04 92 miles
Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection Allergan Recruiting
1
Trial Phase
12
Trial Size
92.04 92 miles
Feasibility and Acceptability of the Hailie Monitoring System in Children With Persistent Asthma Connecticut Children's Medical Center Recruiting N/A
100
Trial Size
92.04 92 miles
Rx for Success: RCT of an App for Dialogic Reading Training Children's Hospital Medical Center, Cincinnati Recruiting N/A
248
Trial Size
92.04 92 miles
OMT to Improve Feeding After Hypothermia Maine Medical Center Recruiting N/A
12
Trial Size
98.71 99 miles
Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage Maine Medical Center Recruiting N/A
40
Trial Size
98.71 99 miles
Short Interval Resveratrol Trial in Cardiovascular Surgery Maine Medical Center Recruiting N/A
40
Trial Size
98.71 99 miles
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors Johns Hopkins University Recruiting N/A
1000
Trial Size
98.71 99 miles
A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Vericel Corporation Recruiting
3
Trial Phase
45
Trial Size
99.22 99 miles
Vaccination Efficacy With Metformin in Older Adults UConn Health Recruiting
1
Trial Phase
40
Trial Size
99.83 100 miles
A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer Dartmouth-Hitchcock Medical Center Recruiting N/A
120
Trial Size
105.25 105 miles
Study of Adjuvant Regorafenib vs Placebo in Patients With Node Positive Esophageal Cancer That Completed Pre-operative Therapy Academic and Community Cancer Research United Recruiting
2
Trial Phase
105
Trial Size
105.25 105 miles
Visual Adaptation Study Dartmouth-Hitchcock Medical Center Recruiting N/A
30
Trial Size
105.25 105 miles
Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance Dartmouth-Hitchcock Medical Center Recruiting N/A
10
Trial Size
105.25 105 miles
A Phase 1b/2, Study of Pegylated Recombinant Human Hyaluronidase Combined With Docetaxel Versus Docetaxel Alone in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC. Halozyme Therapeutics Recruiting
1
Trial Phase
238
Trial Size
105.25 105 miles
Reducing Disability in Older Adult Cancer Survivors Dartmouth-Hitchcock Medical Center Recruiting N/A
72
Trial Size
105.25 105 miles
Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer Dartmouth-Hitchcock Medical Center Recruiting N/A
10
Trial Size
105.25 105 miles
A Proof-of-principle Study of Hyperbaric Oxygen as a Radiosensitizer Prior to Stereotactic Radiosurgery for Brain Metastases Dartmouth-Hitchcock Medical Center Recruiting N/A
22
Trial Size
105.25 105 miles
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors GlaxoSmithKline Recruiting
1
Trial Phase
200
Trial Size
105.25 105 miles
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas Dartmouth-Hitchcock Medical Center Recruiting N/A
200
Trial Size
105.25 105 miles
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy Dartmouth-Hitchcock Medical Center Recruiting
2
Trial Phase
40
Trial Size
105.25 105 miles
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) Teva Pharmaceutical Industries Recruiting
3
Trial Phase
300
Trial Size
105.25 105 miles
Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Dartmouth-Hitchcock Medical Center Recruiting
2
Trial Phase
30
Trial Size
105.65 106 miles
The Role of Emotional Arousal in Food Preference and Taste Yale University Recruiting N/A
150
Trial Size
107.79 108 miles
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers SerenaGroup, Inc. Recruiting
4
Trial Phase
194
Trial Size
109.63 110 miles
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia National Cancer Institute (NCI) Recruiting
1
Trial Phase
54
Trial Size
113.14 113 miles
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis Mallinckrodt Recruiting
4
Trial Phase
232
Trial Size
113.53 114 miles
Ivabradine for Rate Control in Permanent Atrial Fibrillation Yale University Recruiting
1
Trial Phase
15
Trial Size
115.04 115 miles
Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes Yale University Recruiting
0
Trial Phase
30
Trial Size
118.60 119 miles
Safety and Tolerability of Metronidazole Gel 1.3% Watson Pharmaceuticals Recruiting
4
Trial Phase
60
Trial Size
118.60 119 miles
Mindfulness Based Stress Reduction for Metabolic Syndrome Yale University Recruiting N/A
40
Trial Size
118.60 119 miles
A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers Genentech, Inc. Recruiting
1
Trial Phase
449
Trial Size
118.60 119 miles
Galantamine and CBT4CBT Pilot Yale University Recruiting
1
Trial Phase
30
Trial Size
118.60 119 miles
Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements Pfizer Recruiting
1
Trial Phase
32
Trial Size
118.60 119 miles
A Pancreatic Cancer Screening Study in Individuals With New-Onset Diabetes Mellitus Western Connecticut Health Network Recruiting N/A
800
Trial Size
118.60 119 miles
Computer Based Training in Cognitive Behavioral Therapy Web-based Yale University Recruiting
1
Trial Phase
180
Trial Size
118.84 119 miles
Corticosteroid Dosage for Crohn's Disease Flare Yale University Recruiting
4
Trial Phase
182
Trial Size
118.84 119 miles
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System Monteris Medical Recruiting N/A
1000
Trial Size
118.84 119 miles
New Haven MOMS Partnership Yale University Recruiting N/A
160
Trial Size
118.84 119 miles
MOMS Hubs- CT Dept of Social Services Block Grant Yale University Recruiting N/A
120
Trial Size
118.84 119 miles
A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers Mount Sinai School of Medicine Recruiting N/A
1200
Trial Size
118.84 119 miles
An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations Mount Sinai School of Medicine Recruiting N/A
1200
Trial Size
118.84 119 miles
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Associazione Angela Serra per la ricerca sul cancro Recruiting N/A
2000
Trial Size
118.84 119 miles
Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer. Yale University Recruiting
2
Trial Phase
50
Trial Size
118.84 119 miles
Post-Market Surveillance With a Novel mHealth Platform Yale University Recruiting N/A
60
Trial Size
118.84 119 miles
Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects Invicro Recruiting
1
Trial Phase
6
Trial Size
118.84 119 miles
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Yale University Recruiting
1
Trial Phase
15
Trial Size
118.84 119 miles
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors Genmab Recruiting
1
Trial Phase
188
Trial Size
118.84 119 miles
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease Otonomy, Inc. Recruiting
3
Trial Phase
160
Trial Size
118.84 119 miles
Bariatric Scalable Internet Treatments Yale University Recruiting N/A
52
Trial Size
118.84 119 miles
Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques. Yale University Recruiting N/A
50
Trial Size
118.84 119 miles
Comparing an Inexpensive Handheld Ultrasound Machine and a Large Mobile Ultrasound System Yale University Recruiting N/A
75
Trial Size
118.84 119 miles
Immunologic Mechanisms in Neurological Diseases Yale University Recruiting N/A
800
Trial Size
118.84 119 miles
The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms Yale University Recruiting
1
Trial Phase
40
Trial Size
118.84 119 miles
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer Kymab Limited Recruiting
1
Trial Phase
412
Trial Size
118.84 119 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment Yale University Recruiting
3
Trial Phase
180
Trial Size
118.84 119 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment Yale University Recruiting
3
Trial Phase
80
Trial Size
118.84 119 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders Yale University Recruiting
2
Trial Phase
40
Trial Size
118.84 119 miles
SV2 PET Imaging With [11C]APP311 Yale University Recruiting N/A
120
Trial Size
118.84 119 miles
SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients (BCV CMV vGCV) Chimerix Recruiting
3
Trial Phase
520
Trial Size
118.89 119 miles
SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients Chimerix Recruiting
3
Trial Phase
750
Trial Size
118.89 119 miles
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes Medtronic Diabetes Recruiting
3
Trial Phase
150
Trial Size
118.89 119 miles
The Effects of a Moderate Weight Loss on Insulin Resistance Yale University Recruiting N/A
35
Trial Size
118.89 119 miles
Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver. Yale University Recruiting N/A
80
Trial Size
118.89 119 miles
Pilot Study for Verifying Endotracheal Tube Repositioning Using Ultrasound Yale University Recruiting N/A
25
Trial Size
118.89 119 miles
Neurofeedback for Tourette Syndrome Yale University Recruiting N/A
30
Trial Size
118.89 119 miles
A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE) OncoMed Pharmaceuticals, Inc. Recruiting
1
Trial Phase
80
Trial Size
118.89 119 miles
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry Monteris Medical Recruiting N/A
300
Trial Size
118.89 119 miles
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint Agendia Recruiting N/A
1200
Trial Size
118.89 119 miles
Perioperative Blood Pressures and Chronic Hypertension Yale University Recruiting N/A
200
Trial Size
118.89 119 miles
Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders Yale University Recruiting N/A
40
Trial Size
118.89 119 miles
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Northwestern University Recruiting
2
Trial Phase
35
Trial Size
118.89 119 miles
CD40 Agonistic Antibody APX005M in Combination With Nivolumab Apexigen, Inc. Recruiting
1
Trial Phase
99
Trial Size
118.89 119 miles
Human Epilepsy Project 2: Resistant Focal Seizures Study Epilepsy Foundation of America Recruiting N/A
205
Trial Size
118.89 119 miles
The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA Yale University Recruiting
1
Trial Phase
12
Trial Size
118.89 119 miles
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures Yale University Recruiting
4
Trial Phase
100
Trial Size
119.70 120 miles
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) Edwards Lifesciences Recruiting N/A
1025
Trial Size
119.86 120 miles
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS Yale University Recruiting
1
Trial Phase
30
Trial Size
119.86 120 miles
Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET Yale University Recruiting N/A
48
Trial Size
119.86 120 miles
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration Yale University Recruiting
1
Trial Phase
24
Trial Size
119.86 120 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.